{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:35:20Z","timestamp":1794983720918,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61560-0","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T13:05:47Z","timestamp":1751893547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["YY1 enhances HIF-1\u03b1 stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3078-1421","authenticated-orcid":false,"given":"Wenchao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaiSai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-5224","authenticated-orcid":false,"given":"Weipu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-2037","authenticated-orcid":false,"given":"Chuanjun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naipeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5041-7865","authenticated-orcid":false,"given":"Shenghong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-8614","authenticated-orcid":false,"given":"Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-0500","authenticated-orcid":false,"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"61560_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O. et al. 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur. Urol. 84, 191\u2013206 (2023).","journal-title":"Eur. Urol."},{"key":"61560_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist. Updates 68, 100962 (2023).","journal-title":"Drug Resist. Updates"},{"key":"61560_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205\u2013214 (2015).","journal-title":"Cell"},{"key":"61560_CR4","doi-asserted-by":"publisher","first-page":"328rv324","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv324 (2016).","journal-title":"Sci. Transl. Med."},{"key":"61560_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran, D. et al. Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach. Cell Rep. Med. 4, 101199 (2023).","journal-title":"Cell Rep. Med."},{"key":"61560_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu, Q. et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J. Hematol. Oncol. 15, 77 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"61560_CR7","doi-asserted-by":"crossref","unstructured":"Liikanen, I. et al. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. J. Clin. Investig. 131, e143729 (2021).","DOI":"10.1172\/JCI143729"},{"key":"61560_CR8","doi-asserted-by":"crossref","unstructured":"Vito, A., El-Sayes, N. & Mossman, K. Hypoxia-driven immune escape in the tumor microenvironment. Cells 9, 992 (2020).","DOI":"10.3390\/cells9040992"},{"key":"61560_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","volume":"18","author":"CT Taylor","year":"2022","unstructured":"Taylor, C. T. & Scholz, C. C. The effect of HIF on metabolism and immunity. Nat. Rev. Nephrol. 18, 573\u2013587 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"61560_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100787","volume":"59","author":"J Kopecka","year":"2021","unstructured":"Kopecka, J. et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resist. Updates 59, 100787 (2021).","journal-title":"Drug Resist. Updates"},{"key":"61560_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai, R. et al. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol. Cancer 21, 177 (2022).","journal-title":"Mol. Cancer"},{"key":"61560_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni, N. et al. IL-1beta(+) macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623, 415\u2013422 (2023).","journal-title":"Nature"},{"key":"61560_CR13","doi-asserted-by":"crossref","unstructured":"Yamaguchi, Y. et al. PD-L1 blockade restores CAR T cell activity through IFN-gamma-regulation of CD163+ M2 macrophages. J. Immunother. Cancer 10, e004400 (2022).","DOI":"10.1136\/jitc-2021-004400"},{"key":"61560_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg, M. et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell 39, 928\u2013944.e6 (2021).","journal-title":"Cancer Cell"},{"key":"61560_CR15","first-page":"4490","volume":"18","author":"R Sumitomo","year":"2019","unstructured":"Sumitomo, R. et al. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer. Exp. Ther. Med. 18, 4490\u20134498 (2019).","journal-title":"Exp. Ther. Med."},{"key":"61560_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2022.01.026","volume":"530","author":"TJ Li","year":"2022","unstructured":"Li, T. J. et al. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Lett. 530, 142\u2013155 (2022).","journal-title":"Cancer Lett."},{"key":"61560_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/pros.23742","volume":"79","author":"A Erlandsson","year":"2019","unstructured":"Erlandsson, A. et al. M2 macrophages and regulatory T cells in lethal prostate cancer. Prostate 79, 363\u2013369 (2019).","journal-title":"Prostate"},{"key":"61560_CR18","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1158\/0008-5472.CAN-17-3876","volume":"78","author":"V Quaranta","year":"2018","unstructured":"Quaranta, V. et al. Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Res. 78, 4253\u20134269 (2018).","journal-title":"Cancer Res."},{"key":"61560_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1102-3","volume":"18","author":"X Li","year":"2019","unstructured":"Li, X. et al. Harnessing tumor-associated macrophages as aids for cancer immunotherapy. Mol. Cancer 18, 177 (2019).","journal-title":"Mol. Cancer"},{"key":"61560_CR20","doi-asserted-by":"publisher","first-page":"189006","DOI":"10.1016\/j.bbcan.2023.189006","volume":"1878","author":"T Li","year":"2023","unstructured":"Li, T., Zeng, Z., Fan, C. & Xiong, W. Role of stress granules in tumorigenesis and cancer therapy. Biochim. Biophys. Acta Rev. Cancer 1878, 189006 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"61560_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00480-0","volume":"8","author":"S Ambadipudi","year":"2017","unstructured":"Ambadipudi, S., Biernat, J., Riedel, D., Mandelkow, E. & Zweckstetter, M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat. Commun. 8, 275 (2017).","journal-title":"Nat. Commun."},{"key":"61560_CR22","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1093\/nar\/gkad449","volume":"51","author":"D Liu","year":"2023","unstructured":"Liu, D. et al. IFI16 phase separation via multi-phosphorylation drives innate immune signaling. Nucleic Acids Res.51, 6819\u20136840 (2023).","journal-title":"Nucleic Acids Res."},{"key":"61560_CR23","doi-asserted-by":"publisher","first-page":"21890","DOI":"10.1074\/jbc.M115.660621","volume":"290","author":"GZ Wang","year":"2015","unstructured":"Wang, G. Z. & Goff, S. P. Regulation of Yin Yang 1 by tyrosine phosphorylation. J. Biol. Chem. 290, 21890\u201321900 (2015).","journal-title":"J. Biol. Chem."},{"key":"61560_CR24","doi-asserted-by":"publisher","first-page":"592164","DOI":"10.3389\/fcell.2020.592164","volume":"8","author":"TCJ Verheul","year":"2020","unstructured":"Verheul, T. C. J., van Hijfte, L., Perenthaler, E. & Barakat, T. S. The Why of YY1: mechanisms of transcriptional regulation by Yin Yang 1. Front. Cell Dev. Biol. 8, 592164 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"61560_CR25","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1093\/nar\/gkac233","volume":"50","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. Nucleic Acids Res. 50, 4917\u20134937 (2022).","journal-title":"Nucleic Acids Res."},{"key":"61560_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman, M. Z. et al. PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J. Exp. Med. 211, 781\u2013790 (2014).","journal-title":"J. Exp. Med."},{"key":"61560_CR27","doi-asserted-by":"publisher","first-page":"1700833","DOI":"10.1183\/13993003.00833-2017","volume":"50","author":"C Cubillos-Zapata","year":"2017","unstructured":"Cubillos-Zapata, C. et al. Hypoxia-induced PD-L1\/PD-1 crosstalk impairs T-cell function in sleep apnoea. Eur. Respir. J. 50, 1700833 (2017).","journal-title":"Eur. Respir. J."},{"key":"61560_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294\u2013309 (2010).","journal-title":"Mol. Cell"},{"key":"61560_CR29","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","volume":"20","author":"N Masson","year":"2001","unstructured":"Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. & Ratcliffe, P. J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197\u20135206 (2001).","journal-title":"EMBO J."},{"key":"61560_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nature00991","volume":"419","author":"C Hoege","year":"2002","unstructured":"Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135\u2013141 (2002).","journal-title":"Nature"},{"key":"61560_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-020-0137-7","volume":"5","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., He, J., Li, Y., Lv, S. & Cui, H. NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct. Target. Ther. 5, 44 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61560_CR32","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.7150\/ijbs.80017","volume":"19","author":"H Zheng","year":"2023","unstructured":"Zheng, H. et al. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int. J. Biol. Sci. 19, 4689\u20134708 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"61560_CR33","doi-asserted-by":"publisher","first-page":"17178","DOI":"10.1074\/jbc.M117.796045","volume":"292","author":"CA Mills","year":"2017","unstructured":"Mills, C. A. et al. Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation. J. Biol. Chem. 292, 17178\u201317189 (2017).","journal-title":"J. Biol. Chem."},{"key":"61560_CR34","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/MCB.21.17.5979-5991.2001","volume":"21","author":"YL Yao","year":"2001","unstructured":"Yao, Y. L., Yang, W. M. & Seto, E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21, 5979\u20135991 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"61560_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal, A. C. O. Signalling mechanisms and cellular functions of SUMO. Nat. Rev. Mol. Cell Biol. 23, 715\u2013731 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61560_CR36","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","volume":"83","author":"M Wei","year":"2023","unstructured":"Wei, M., Huang, X., Liao, L., Tian, Y. & Zheng, X. SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer Res. 83, 2908\u20132923 (2023).","journal-title":"Cancer Res."},{"key":"61560_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1681\/ASN.2020101398","volume":"32","author":"PE Pergola","year":"2021","unstructured":"Pergola, P. E., Rosenbaum, D. P., Yang, Y. & Chertow, G. M. A Randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY). J. Am. Soc. Nephrol. 32, 1465\u20131473 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"61560_CR38","doi-asserted-by":"publisher","first-page":"15919","DOI":"10.1073\/pnas.1312197110","volume":"110","author":"M Cieslewicz","year":"2013","unstructured":"Cieslewicz, M. et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc. Natl. Acad. Sci. USA 110, 15919\u201315924 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61560_CR39","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.3390\/cancers15133506","volume":"15","author":"R Hosea","year":"2023","unstructured":"Hosea, R., Hillary, S., Wu, S. & Kasim, V. Targeting transcription factor YY1 for cancer treatment: current strategies and future directions. Cancers 15, 3506 (2023).","journal-title":"Cancers"},{"key":"61560_CR40","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li, K. & Crews, C. M. PROTACs: past, present and future. Chem. Soc. Rev. 51, 5214\u20135236 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"61560_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40244-7","volume":"14","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. DNA framework-engineered chimeras platform enables selectively targeted protein degradation. Nat. Commun. 14, 4510 (2023).","journal-title":"Nat. Commun."},{"key":"61560_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1615\/CritRevOncog.v16.i3-4.20","volume":"16","author":"M Atchison","year":"2011","unstructured":"Atchison, M., Basu, A., Zaprazna, K. & Papasani, M. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Crit. Rev. Oncog. 16, 143\u2013161 (2011).","journal-title":"Crit. Rev. Oncog."},{"key":"61560_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","volume":"25","author":"S Gordon","year":"2006","unstructured":"Gordon, S., Akopyan, G., Garban, H. & Bonavida, B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125\u20131142 (2006).","journal-title":"Oncogene"},{"key":"61560_CR44","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.7150\/thno.43481","volume":"10","author":"ITS Meliala","year":"2020","unstructured":"Meliala, I. T. S., Hosea, R., Kasim, V. & Wu, S. The biological implications of Yin Yang 1 in the hallmarks of cancer. Theranostics 10, 4183\u20134200 (2020).","journal-title":"Theranostics"},{"key":"61560_CR45","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1158\/0008-5472.CAN-17-4047","volume":"78","author":"S Wu","year":"2018","unstructured":"Wu, S. et al. Transcription factor YY1 promotes cell proliferation by directly activating the pentose phosphate pathway. Cancer Res. 78, 4549\u20134562 (2018).","journal-title":"Cancer Res."},{"key":"61560_CR46","doi-asserted-by":"publisher","first-page":"e006020","DOI":"10.1136\/jitc-2022-006020","volume":"11","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J. Immunother. Cancer 11, e006020 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"61560_CR47","doi-asserted-by":"publisher","first-page":"eaaf4382","DOI":"10.1126\/science.aaf4382","volume":"357","author":"Y Shin","year":"2017","unstructured":"Shin, Y. & Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science 357, eaaf4382 (2017).","journal-title":"Science"},{"key":"61560_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","volume":"595","author":"JH Ahn","year":"2021","unstructured":"Ahn, J. H. et al. Phase separation drives aberrant chromatin looping and cancer development. Nature 595, 591\u2013595 (2021).","journal-title":"Nature"},{"key":"61560_CR49","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2018.06.006","volume":"174","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell 174, 688\u2013699.e16 (2018).","journal-title":"Cell"},{"key":"61560_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22297-8","volume":"12","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein. Nat. Commun. 12, 2114 (2021).","journal-title":"Nat. Commun."},{"key":"61560_CR51","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.1093\/nar\/gkac1194","volume":"50","author":"C Her","year":"2022","unstructured":"Her, C. et al. Molecular interactions underlying the phase separation of HP1alpha: role of phosphorylation, ligand and nucleic acid binding. Nucleic Acids Res. 50, 12702\u201312722 (2022).","journal-title":"Nucleic Acids Res."},{"key":"61560_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41420-024-01858-y","volume":"10","author":"Y Jang","year":"2024","unstructured":"Jang, Y., Kang, S., Han, H. H., Kim, B. G. & Cho, N. H. CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a\/301a-dependent CDK19 downregulation. Cell Death Discov. 10, 81 (2024).","journal-title":"Cell Death Discov."},{"key":"61560_CR53","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/CIRCRESAHA.121.319296","volume":"129","author":"SY Wei","year":"2021","unstructured":"Wei, S. Y. et al. Endothelial Yin Yang 1 phosphorylation at S118 induces atherosclerosis under flow. Circ. Res. 129, 1158\u20131174 (2021).","journal-title":"Circ. Res."},{"key":"61560_CR54","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"61560_CR55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217840120","volume":"120","author":"A Bononi","year":"2023","unstructured":"Bononi, A. et al. BAP1 is a novel regulator of HIF-1alpha. Proc. Natl. Acad. Sci. USA 120, e2217840120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61560_CR56","doi-asserted-by":"publisher","first-page":"16123","DOI":"10.1007\/s00432-023-05310-z","volume":"149","author":"K Li","year":"2023","unstructured":"Li, K. et al. The SUMOylation and ubiquitination crosstalk in cancer. J. Cancer Res. Clin. Oncol. 149, 16123\u201316146 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"61560_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cell.2007.07.044","volume":"131","author":"A Carbia-Nagashima","year":"2007","unstructured":"Carbia-Nagashima, A. et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131, 309\u2013323 (2007).","journal-title":"Cell"},{"key":"61560_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ccr.2013.12.008","volume":"25","author":"J Li","year":"2014","unstructured":"Li, J. et al. Cbx4 governs HIF-1alpha to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell 25, 118\u2013131 (2014).","journal-title":"Cancer Cell"},{"key":"61560_CR59","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1083\/jcb.200302129","volume":"162","author":"T Raemaekers","year":"2003","unstructured":"Raemaekers, T. et al. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J. Cell Biol. 162, 1017\u20131029 (2003).","journal-title":"J. Cell Biol."},{"key":"61560_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/or.2024.8722","volume":"51","author":"M Zheng","year":"2024","unstructured":"Zheng, M. et al. MITF regulates the subcellular location of HIF1alpha through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells. Oncol. Rep. 51, 63 (2024).","journal-title":"Oncol. Rep."},{"key":"61560_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117859","volume":"255","author":"X Lin","year":"2020","unstructured":"Lin, X. et al. Sumoylation enhances the activity of the TGF-beta\/SMAD and HIF-1 signaling pathways in keloids. Life Sci. 255, 117859 (2020).","journal-title":"Life Sci."},{"key":"61560_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61560_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39173-2","volume":"14","author":"J Du","year":"2023","unstructured":"Du, J. et al. Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis. Nat. Commun. 14, 3675 (2023).","journal-title":"Nat. Commun."},{"key":"61560_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk1692","volume":"7","author":"T Hoch","year":"2022","unstructured":"Hoch, T. et al. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy. Sci. Immunol. 7, eabk1692 (2022).","journal-title":"Sci. Immunol."},{"key":"61560_CR65","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"61560_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat. Commun. 12, 1394 (2021).","journal-title":"Nat. Commun."},{"key":"61560_CR67","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform. 19, 578\u2013583 (2021).","journal-title":"Genom. Proteom. Bioinform."},{"key":"61560_CR68","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"53","author":"CNCB-NGDC Members and Partners","year":"2025","unstructured":"CNCB-NGDC Members and Partners Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 53, D30\u2013D44 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61560-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:02:32Z","timestamp":1751896952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61560-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61560"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61560-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All human tumor tissue samples were collected in accordance with the national and institutional ethical guidelines. The study design was approved by the Ethics Committee of Zhongda Hospital, Southeast University. The approval ID is 2022ZDKYSB099. All animal experimental protocols were approved by the Ethics Committee of Zhongda Hospital, Southeast University, and conducted following the National Guidelines for the Health Use of Laboratory Animals. The approval ID is 20220225034.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"6261"}}